Where is the future mainstream direction of the medical device industry
This year is a year when government policies strongly support pharmaceutical devices, and the domestic medical device market is bound to usher in more opportunities. Shi Yonghui, head of the investment and mergers and acquisitions department of Medtronic Greater China, a global orthopedic medical device giant, believes that the state's rectification of illegal activities by foreign-funded enterprises is of great benefit to the regulation of the entire medical industry.
my country's medical device companies will not reproduce the high growth rate of 30% in previous years, but as the country encourages domestic medical devices to improve performance and upgrade, it will bring more opportunities for rapid development of China's medical device industry.
For example: my country's cardiovascular and cerebrovascular medical device industry is facing four major development opportunities. First of all, in terms of biodegradable heart stents, the gap between my country's technological level and the international level is relatively small, and it has the opportunity to participate in international competition and enter the world. In the next 3-5 years, the entry of Chinese companies will cause the global degradable heart stent market to enter a reshuffle stage.
Secondly, in the device market such as pacemakers, currently monopolized by foreign-funded enterprises, domestically-made devices account for only 12%. Under the background that the country encourages domestic-made medical devices to upgrade and the government increases procurement, there is a great opportunity for domestic-made devices to substitute increase.
Third, in terms of three-dimensional mapping equipment, although the market segment has a small capacity, the growth rate is fast; finally, there are great opportunities for preventive testing. "In view of the fact that my country has 200 million people with high blood pressure and 100 million people with diabetes, the trend of my country’s medical resources in short supply is difficult to change for a long time. Therefore, opportunities for prevention and testing products are also rising. Such as implantable monitoring devices, external heart Electric monitoring technology and services are expected to receive more attention.
Mergers and acquisitions of domestic medical device companies may become mainstream
Medtronic has recently made frequent moves and has successively acquired two machinery companies, Aircraft and Lazarus Effect. The cases of mergers and acquisitions of foreign-funded enterprises are also emerging this year. So should domestic medical device companies also adjust their strategies?
From the perspective of the development path of medical device giants such as Medtronic, the main reason for continuous expansion and strengthening is to take the route of reorganization and mergers. At present, China's medical device industry is also copying the growth path of foreign giants.
According to relevant data, driven by steady growth in demand and extensional mergers and acquisitions, the third quarterly report of the pharmaceutical sector has the highest pre-increasing ratio, reaching more than 70%. The agency expects that medical devices, as a subdivision of the pharmaceutical industry, are expected to usher in accelerated development opportunities driven by the latest policies to promote the construction of health and elderly care services, hierarchical diagnosis and treatment, and the localization of medical devices.
